• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease.

作者信息

Ebisawa Kazutoshi, Masamoto Yosuke, Tokushige Junji, Nishi Hiroshi, Honda Kenjiro, Hinata Munetoshi, Toyama Kazuhiro, Nangaku Masaomi, Kurokawa Mineo

机构信息

Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Department of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

出版信息

Ann Hematol. 2019 Aug;98(8):1995-1997. doi: 10.1007/s00277-019-03616-y. Epub 2019 Feb 13.

DOI:10.1007/s00277-019-03616-y
PMID:30761408
Abstract
摘要

相似文献

1
Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease.托珠单抗治疗多中心Castleman病继发的局灶节段性肾小球硬化症。
Ann Hematol. 2019 Aug;98(8):1995-1997. doi: 10.1007/s00277-019-03616-y. Epub 2019 Feb 13.
2
Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.长期使用托珠单抗治疗后的特发性多中心Castleman病中的白细胞介素-6
Ann Hematol. 2017 Dec;96(12):2117-2119. doi: 10.1007/s00277-017-3111-x. Epub 2017 Sep 1.
3
Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman's disease by an anti-interleukin-6 receptor antibody (tocilizumab).通过抗白细胞介素-6受体抗体（托珠单抗）成功治疗伴有卡斯特曼病的系膜增生性肾小球肾炎合并间质性肾炎。
Intern Med. 2012;51(11):1375-8. doi: 10.2169/internalmedicine.51.6555. Epub 2012 Jun 1.
4
Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.使用抗白细胞介素-6受体抗体托珠单抗成功治疗了一名患有多中心Castleman病的患者，该患者出现血小板减少、腹水、肾衰竭和骨髓纤维化。
Intern Med. 2013;52(13):1503-7. doi: 10.2169/internalmedicine.52.9482. Epub 2013 Jul 1.
5
Successful treatment of multicentric Castleman's disease associated with dystrophic epidermolysis bullosa using anti-interleukin-6 receptor antibody.使用抗白细胞介素-6受体抗体成功治疗与营养不良性大疱性表皮松解症相关的多中心Castleman病。
J Dermatol. 2024 Aug;51(8):e268-e269. doi: 10.1111/1346-8138.17172. Epub 2024 Mar 14.
6
Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease.抗白细胞介素6受体抗体托珠单抗可降低多中心Castleman病患者的血清铁调素水平。
Haematologica. 2007 Jun;92(6):857-8. doi: 10.3324/haematol.10794.
7
Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab.两例特发性多中心 Castleman 病伴肾病综合征患者采用托珠单抗治疗。
CEN Case Rep. 2021 Feb;10(1):35-41. doi: 10.1007/s13730-020-00511-8. Epub 2020 Jul 26.
8
Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.抗白细胞介素-6受体抗体（托珠单抗）治疗多中心性Castleman病。
Intern Med. 2007;46(11):771-4. doi: 10.2169/internalmedicine.46.6262. Epub 2007 Jun 1.
9
Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis.结节病17年随访期间发生的混合型多中心Castleman病。
Intern Med. 2012;51(21):3061-6. doi: 10.2169/internalmedicine.51.8120. Epub 2012 Nov 1.
10
Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.与多发性 Castleman 病相关的膜性肾病，经托珠单抗治疗后成功：病例报告及文献复习。
BMC Nephrol. 2021 Jun 9;22(1):216. doi: 10.1186/s12882-021-02423-w.

引用本文的文献

1
Tocilizumab-induced immunocomplex glomerulonephritis: a report of two cases.托珠单抗诱导免疫复合物性肾小球肾炎：两例报告。
CEN Case Rep. 2020 Nov;9(4):318-325. doi: 10.1007/s13730-020-00478-6. Epub 2020 Apr 27.